Precision Bio Sciences Promotes Naresh Tanna To Vice President of Investor Relations
02/13/24, 12:04 PM
Location
durhamIndustry
genetics
therapeutics
biotechnology
health care
Position
vice president of investor relations
Precision BioSciences, Inc. announced the promotion of Naresh Tanna from Chief of Staff to the CEO to Vice President of Investor Relations to enhance and expand its IR program and communications with shareholders.
Company Info
Location
302 east pettigrew street
durham, north carolina, united states
Additional Info
Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina.